Glucagon-Like Peptide-1 (GLP-1) Suppression of Alpha Cell Secretion in Type 2 Diabetes Mellitus (T2DM)

Clinical trial NCT00862589 · COMPLETED

Trial details

NCT number: NCT00862589
Sponsor: University Hospital, Gentofte, Copenhagen
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Hyperglycemia Hyperglucagonemia Glucose Intolerance

Start date: 2006-10-01
Primary completion: 2007-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.